Skip to main content
Premium Trial:

Request an Annual Quote

Cellzome Snags More Than $3.1M in Grants for EU-, UK-Sponsored Research Initiatives


Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.

The funding supports Cellzome’s work in: Blueprint, an EU-funded effort to analyze the epigenome of the hematopoietic system; Orchid, an EU-funded project in which Cellzome will work under the direction of drugmaker GlaxoSmithKline to identify new drug targets in tuberculosis; and a stem cell characterization project the company has undertaken in collaboration with Pfizer, the University of Sheffield, and the stem cell firm Plasticell (see story this issue).

The company will receive €1.2 million for its work on the Blueprint project, €1.1 million for its stem cell research, and an undisclosed amount for its participation in the Orchid project, which, according to Cellzome chief scientific officer David Simmons, will be centered at GSK’s “Open Lab” in Tres Cantos, Spain.

Cellzome will be using its Episphere and Kinobeads chemoproteomics platforms in these projects, as well as mass spec-based proteome-wide screening methods.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.